Alector Inc. (ALEC)
NASDAQ: ALEC
· Real-Time Price · USD
1.20
0.03 (2.56%)
At close: May 12, 2025, 3:59 PM
1.20
0.00%
Pre-market: May 13, 2025, 04:20 AM EDT
2.56% (1D)
| Bid | 1.19 |
| Market Cap | 119.99M |
| Revenue (ttm) | 100.56M |
| Net Income (ttm) | -119.05M |
| EPS (ttm) | -1.23 |
| PE Ratio (ttm) | -0.98 |
| Forward PE | -0.72 |
| Analyst | Buy |
| Ask | 1.47 |
| Volume | 1,077,267 |
| Avg. Volume (20D) | 761,337 |
| Open | 1.21 |
| Previous Close | 1.17 |
| Day's Range | 1.19 - 1.25 |
| 52-Week Range | 0.87 - 6.78 |
| Beta | 0.76 |
About ALEC
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ALEC
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ALEC stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsEarnings Surprise
Alector has released their quartely earnings
on May 8, 2025:
5 months ago
-13.1%
Alector shares are trading lower after the company...
Unlock content with
Pro Subscription
5 months ago
-35.1%
Alector shares are trading lower after the company announced that the INVOKE-2 Phase 2 clinical trial evaluating the safety and efficacy of AL002 in individuals with early Alzheimer's disease failed to meet its primary endpoint.
